4//SEC Filing
Anika Therapeutics, Inc. 4
Accession 0001171843-17-003991
$ANIKCIK 0000898437operating
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:30 PM ET
Size
7.2 KB
Accession
0001171843-17-003991
Insider Transaction Report
Form 4
SHERWOOD CHARLES H
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2017-07-03$50.00/sh−5,965$298,250→ 246,740 total - Sale
Common Stock
2017-07-05$50.06/sh−8,236$412,294→ 238,504 total
Footnotes (2)
- [F1]On July 3, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 5,965 shares in multiple trades ranging from $50.00 to $50.02. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.
- [F2]On July 5, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 8,236 shares in multiple trades ranging from $50.00 to $50.25. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000898437
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 6:30 PM ET
- Size
- 7.2 KB